Antianginal medicated compound

The anginal medicated compound according to the present invention comprises the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo-/3,3,0/-octanedione-3,7 of the formula: in combination with a pharmaceutical carrier. The medicated compound according to the present invention is useful for t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VALIMUKHAMETOVA, DANIA A, KAMBURG, ROMAN A, KHMELNITSKY, LENOR I, BOGOYAVLENSKY, VLADIMIR F, KAVERINA, NATALYA V, EPISHINA, LIA V, LAPSHINA, LIDIA V, KARPOV, ANATOLY M, SUVOROVA, LJUDMILA I, DARINSKY, NIKOLAI V, NOVIKOV, DECEASED, SERGEI S, ZAIKONNIKOVA, IRINA V, ZIMAKOVA, IRINA E, LEBEDEV, OLEG V
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The anginal medicated compound according to the present invention comprises the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo-/3,3,0/-octanedione-3,7 of the formula: in combination with a pharmaceutical carrier. The medicated compound according to the present invention is useful for the treatment of patients suffering from ischemic heart disease.